Pet DNA Testing Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, Test Type, End-user, Sample Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Pet DNA Testing Market size stood at USD 486.5 million in 2026 and is predicted to grow at a 9.69% CAGR from 2027 to 2036, exceeding USD 1.23 billion by 2036. The industry revenue for 2027 is calculated at USD 526.2 million.
Get more details on this report
Request Free Sample ReportPet DNA Testing Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 44.31% share, driven by high pet care spending, strong consumer awareness, veterinary integration of genetic testing, and established e-commerce channels supporting routine adoption.
- Asia Pacific’s 10.51% CAGR is supported by rising pet ownership, urbanization, premium pet care demand, expanding digital retail access, and growing awareness of breed and health insights.
Segment Momentum
- Dogs lead with 54.66% share due to widespread DNA testing for breed identification, lineage tracking and trait analysis, strongly integrated into adoption, breeding and routine pet care decisions.
- Health and Wellness is the fastest-growing test type as pet owners increasingly seek preventive care-oriented genetic insights that support individualized health management and awareness of inherited risks.
Market Expansion Drivers
- Rising pet ownership and consumer spending on pet health driving DNA testing adoption.
- Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits.
- Growing premiumization of pet care and personalized veterinary diagnostics services.
Leading Market Participants
- Leading players in the pet DNA testing market include Mars Petcare Inc. (United States), Zoetis Inc. (United States), Embark Veterinary, Inc. (United States), Neogen Corporation (United States), Orivet Genetic Pet Care Limited (Australia), Macrogen, Inc. (South Korea), Genetic Technologies Limited (Australia), DNA My Dog Inc. (Canada), Clinomics Inc. (South Korea).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 486.5 million
- 2027 Estimated Market Size: USD 526.2 million.
- Projected Market Size: USD 1.23 billion by 2036
- Growth Forecast: 9.69% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Dogs (Animal Type) | Breed Profile (Test Type) | Breeders (End-user) | Saliva (Sample Type)
- Emerging Opportunity Segment: Cats (Animal Type) | Health and Wellness (Test Type) | Pet Owners (End-user) | Blood (Sample Type)
Market Growth Drivers and Industry Trends
Rising pet ownership and consumer spending on pet health driving DNA testing adoption
Rising pet ownership and greater spending on animal health are strengthening demand in the pet DNA testing market, as owners increasingly seek deeper insights into breed composition, inherited traits, and potential health risks. Increased attention to preventive pet care encourages consumers to use genetic information alongside routine veterinary services when making decisions about nutrition, wellness, and ongoing health management.
Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits
Lower-cost genomic sequencing technologies are making genetic testing more accessible, supporting the pet DNA testing market by enabling the development of convenient at-home testing kits. Greater affordability can broaden adoption beyond specialized veterinary settings, while simplified sample collection and home-based testing allow pet owners to obtain genetic information without relying exclusively on clinic-based diagnostic processes.
Growing premiumization of pet care and personalized veterinary diagnostics services
The growing willingness to invest in higher-value pet care is creating demand for more personalized diagnostic services, thereby supporting the pet DNA testing market. Pet owners increasingly view advanced health information as part of comprehensive animal care, while veterinary providers can use genetic insights to complement individualized health assessments and inform more tailored approaches to managing pets' needs.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet ownership and consumer spending on pet health driving DNA testing adoption | 2.50% | Low | North America, Europe | High | Near Term |
| Advancements in affordable genomic sequencing expanding accessibility of at-home pet testing kits | 2.30% | Moderate | North America, Asia Pacific | High | Near Term |
| Growing premiumization of pet care and personalized veterinary diagnostics services | 1.90% | Moderate | North America, Europe | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the pet DNA testing market, accounting for 44.31% share in 2026. The region’s leading position is supported by high levels of pet ownership, strong consumer interest in preventive pet care, and growing acceptance of genetic testing as a tool for understanding breed composition, inherited traits, and potential health risks. A well-developed veterinary ecosystem also supports market adoption by creating opportunities for genetic information to complement routine diagnostics and personalized care. In addition, relatively high household spending on companion animals encourages demand for premium pet health services, while increasing awareness among owners about responsible breeding and early identification of hereditary conditions further strengthens the market.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to represent the fastest-growing regional market, driven by expanding companion animal ownership, rising disposable incomes, and increasing awareness of veterinary healthcare and animal wellness. Urbanization is contributing to a shift toward greater investment in pets as household companions, particularly in major metropolitan areas where access to specialized veterinary services is improving. The gradual development of veterinary infrastructure, broader availability of digital pet-care services, and growing interest in genetic-based approaches to animal health are also creating favorable conditions for adoption. As awareness of pet genetics expands and consumers become more willing to seek personalized care solutions, demand for DNA testing is likely to gain momentum across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Preventive Pet GeneticsGermany is integrating pet DNA testing into preventive veterinary care and responsible breeding practices. Pet owners increasingly seek genetic insights that support early health management and informed long-term care decisions.
France 🇫🇷
Responsible Breeding SupportFrance utilizes pet DNA testing to strengthen responsible breeding practices and improve hereditary disease awareness. Veterinary professionals and breeders increasingly value reliable genetic screening that supports informed breeding and healthcare decisions.
Italy 🇮🇹
Personalized Veterinary InsightsItaly is seeing greater adoption of pet DNA testing as owners seek individualized health information for companion animals. Market participants focus on accessible testing services that help veterinarians tailor preventive care and breed-specific health management.
Japan 🇯🇵
Companion Animal WellnessJapan's growing focus on companion animal health supports demand for pet DNA testing services. Providers emphasize user-friendly testing solutions that deliver breed information and actionable genetic health insights for pet owners and veterinarians.
South Korea 🇰🇷
Digital Pet Care IntegrationSouth Korea is incorporating pet DNA testing into a broader digital pet healthcare ecosystem. Service providers combine genetic analysis with mobile health platforms and personalized wellness recommendations to improve long-term pet management.
United States 🇺🇸
Consumer Genomics AdoptionThe U.S. pet DNA testing market benefits from strong consumer interest in breed identification, inherited health screening, and personalized pet care. Companies continue expanding genomic databases and veterinary partnerships to enhance testing accuracy and service offerings.
Segment Leadership and Growth Trends
Pet DNA Testing Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
The dogs segment dominated the pet DNA testing market with a 54.66% share in 2026, supported by strong consumer interest in breed identification, ancestry assessment, and inherited-trait information. Dog owners increasingly use genetic testing to gain deeper insight into their pets' characteristics and potential health considerations, while the broad diversity of dog breeds creates a substantial use case for DNA-based identification and profiling services.
Cats represent the faster-growing animal type as awareness of feline genetic testing expands among pet owners and veterinary professionals. Increasing interest in breed ancestry, inherited characteristics, and personalized health information is broadening the role of DNA analysis beyond traditional dog-focused testing, while greater availability of feline-specific testing services is supporting market expansion.
Test Type Segment Analysis: Breed Profile (Largest Segment) vs Health and Wellness (Fastest-Growing Segment)
Breed profile held the leading position in the pet DNA testing market, accounting for 40.35% share in 2026, as pet owners continue to seek genetic insights into breed composition, ancestry, and physical characteristics. The appeal of understanding a pet's genetic background, particularly for mixed-breed animals, provides a straightforward and accessible entry point into consumer genetic testing and supports sustained demand for breed-focused services.
Health and wellness testing is growing more rapidly as pet owners become increasingly interested in proactive approaches to animal care and genetic risk assessment. Greater awareness of hereditary conditions and the potential value of genetic information for informing veterinary discussions is encouraging broader adoption of health-oriented testing, shifting the category toward more comprehensive pet wellness applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Dogs, Cats, Others | Dogs | Cats |
| Test Type | Breed Profile, Genetic Diseases, Health and Wellness | Breed Profile | Health and Wellness |
| End-user | Pet Owners, Breeders, Veterinarians | Breeders | Pet Owners |
| Sample Type | Blood, Saliva, Fecal, Others | Saliva | Blood |
Competitive Landscape and Market Positioning
Key companies in the pet DNA testing market:
1. Mars Petcare Inc. (United States)
2. Zoetis Inc. (United States)
3. Embark Veterinary Inc. (United States)
4. Neogen Corporation (United States)
5. Orivet Genetic Pet Care Limited (Australia)
6. Macrogen Inc. (South Korea)
7. Genetic Technologies Limited (Australia)
8. DNA My Dog Inc. (Canada)
9. Clinomics Inc. (South Korea)
The pet DNA testing market is expanding as pet owners increasingly seek insights into genetic traits and health predispositions. Advances in genomic analysis are improving testing accuracy and result interpretation. New service offerings are enabling more detailed breed and health profiling. The pet DNA testing market continues to evolve with rising demand for personalized pet healthcare insights.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Mars Petcare Inc. (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| Embark Veterinary Inc. (United States) | |||||||
| Neogen Corporation (United States) | |||||||
| Orivet Genetic Pet Care Limited (Australia) | |||||||
| Macrogen Inc. (South Korea) | |||||||
| Genetic Technologies Limited (Australia) | |||||||
| DNA My Dog Inc. (Canada) | |||||||
| Clinomics Inc. (South Korea). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| The Kennel Club | Feb-25 | The Kennel Club introduced two DNA testing schemes targeting gangliosidosis (GM1_2 and GM2_2) in Japanese Shiba Inu dogs. The initiative supports genetic screening to identify carriers and affected dogs, strengthening breeding program accuracy and contributing to the reduction of inherited neurological diseases in purebred populations. |
| DNA My Dog | Jan-25 | DNA My Dog partnered with DreamWorks Animation’s Dog Man franchise to launch a sweepstakes integrating pet DNA testing with entertainment engagement. The initiative aims to increase consumer awareness of breed identification testing while enhancing customer acquisition through cross-industry promotional collaboration. |
| University of Cambridge & Wisdom Panel | Aug-24 | Researchers at the University of Cambridge, supported by Wisdom Panel, developed a DNA test aimed at eliminating progressive retinal atrophy in English Shepherd Dogs. The development advances genetic screening tools for inherited disease prevention and supports improved selective breeding strategies in companion animal populations. |
| Mars | Jul-24 | Mars completed the acquisition of Cerba Vet and Antagene, expanding its veterinary diagnostics and animal DNA testing capabilities in France. The acquisition enhances Mars’ position in pet genomics and veterinary diagnostics by integrating laboratory infrastructure and specialized DNA testing services for companion animal health and genetic disease identification. |
| Ancestry | Sep-23 | Ancestry launched its first pet DNA testing product, “Know Your Pet DNA,” expanding beyond human ancestry testing into the companion animal genomics segment. The move diversifies its product portfolio and establishes entry into the growing consumer pet genetics market. |
| Embark Veterinary | Oct-21 | Embark Veterinary launched a DNA test designed for purebred dogs, expanding its canine genetics portfolio. The product strengthens its competitive positioning in pet genomics by offering targeted breed-specific genetic insights for health, lineage, and disease risk assessment. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Pet DNA Testing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Service Model | Direct-to-consumer testing, Veterinary-assisted testing, Breeder-focused testing, Laboratory testing services |
| Pricing Model | Basic testing, Multi-test packages, Premium comprehensive testing, Subscription-based services |
| Distribution Channel | Direct online sales, Veterinary clinics, Pet specialty retailers, Laboratory and diagnostic providers |
Pet DNA Testing Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Pet Genetics Innovation Landscape |
|
| Veterinary Adoption Opportunity Assessment |
|
| Pet Healthcare Ecosystem Integration Strategy |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the pet DNA testing market?
What are the growth projections for the pet DNA testing industry?
How is rising consumer spending on pets reshaping demand in the pet DNA testing market?
How is affordability and direct-to-consumer distribution influencing adoption of pet DNA testing kits?
Why do dogs lead the pet DNA testing market?
What is driving growth in Health and Wellness testing in pet DNA testing market?
Why does North America lead the pet DNA testing market?
What is driving growth in Asia Pacific’s pet DNA testing market?
Which companies are driving growth in the pet DNA testing landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization